Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

NatWest (RBSPF) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for NatWest (RBSPF) over the last 17 years, with Q4 2025 value amounting to $139.4 billion.

  • NatWest's Cash & Equivalents fell 856.55% to $139.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $139.4 billion, marking a year-over-year decrease of 856.55%. This contributed to the annual value of $138.3 billion for FY2025, which is 897.19% down from last year.
  • According to the latest figures from Q4 2025, NatWest's Cash & Equivalents is $139.4 billion, which was down 856.55% from $139.9 billion recorded in Q2 2025.
  • Over the past 5 years, NatWest's Cash & Equivalents peaked at $240.2 billion during Q2 2022, and registered a low of $139.4 billion during Q4 2025.
  • Over the past 5 years, NatWest's median Cash & Equivalents value was $173.5 billion (recorded in 2021), while the average stood at $176.4 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 5577.49% in 2021, then crashed by 2435.74% in 2024.
  • Over the past 5 years, NatWest's Cash & Equivalents (Quarter) stood at $194.6 billion in 2021, then rose by 23.44% to $240.2 billion in 2022, then decreased by 18.11% to $196.7 billion in 2023, then dropped by 22.45% to $152.5 billion in 2024, then decreased by 8.57% to $139.4 billion in 2025.
  • Its Cash & Equivalents stands at $139.4 billion for Q4 2025, versus $139.9 billion for Q2 2025 and $152.5 billion for Q4 2024.